Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 12/20 | 0.74 |
| ▸ | LPAR1 | Q92633 | 10/20 | 0.74 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.55 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.54 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.52 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1534300 | 1.00 | LPAR3 (0.74) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL4435249 | 1.00 | LPAR3 (0.74) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL30443625 | 0.98 | LPAR3 (0.77) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL6225095 | 0.98 | LPAR3 (0.77) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL30556755 | 0.98 | LPAR3 (0.77) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| Glycerin SCHEMBL27912356 | 0.93 | LPAR3 (0.69) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| Monoethanolamine SCHEMBL27933634 | 0.91 | LPAR3 (0.68) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL30137737 | 0.90 | LPAR1 (0.66) | LPAR3LPAR1LPAR2S1PR1ENPP2 | |
| SCHEMBL7212085 | 0.88 | LPAR5 (0.69) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL2732573 | 0.87 | LPAR3 (0.97) | LPAR3LPAR1LPAR2LPAR5LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2576799-B1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | UNIV SAARLAND (DE) | 2017-04-26 | — | — | EP | claimed |
| US-9574215-B2 | Production of fatty acids by heterologous expression of gene clusters from myxobacteria | UNIVERSITAT DES SAARLANDES (DE) | 2017-02-21 | — | — | US | claimed |
| US-20160017388-A1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | UNIV SAARLAND (DE) | 2016-01-21 | — | — | US | claimed |
| US-9127298-B2 | Production of fatty acids by heterologous expression of gene clusters from myxobacteria | UNIVERSITAET DES SAARLANDES (DE) | 2015-09-08 | — | — | US | claimed |
| US-20130196391-A1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | UNIVERSITAET DES SAARLANDES (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2576799-A1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | Universität des Saarlandes (DE) | 2013-04-10 | — | — | EP | claimed |
| JP-7258278-A | — | — | None | — | — | JP | disclosed |
| EP-4330249-A1 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | Viva Star Biosciences (Suzhou) Co., Ltd. (CN) | 2024-03-06 | — | — | EP | disclosed |
| US-20230310564-A1 | Attenuated Mycoplasma Bacteria | INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ES) | 2023-10-05 | — | — | US | disclosed |
| EP-4121445-A1 | ATTENUATED MYCOPLASMA BACTERIA | Fundació Centre de Regulació Genòmica (ES) | 2023-01-25 | — | — | EP | disclosed |
| WO-2021186052-A1 | ATTENUATED MYCOPLASMA BACTERIA | FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (ES) | 2021-09-23 | — | — | WO | disclosed |
| EP-2576799-B1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | UNIV SAARLAND (DE) | 2017-04-26 | — | — | EP | disclosed |
| US-9574215-B2 | Production of fatty acids by heterologous expression of gene clusters from myxobacteria | UNIVERSITAT DES SAARLANDES (DE) | 2017-02-21 | — | — | US | disclosed |
| US-20130196391-A1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | UNIVERSITAET DES SAARLANDES (DE) | 2013-08-01 | — | — | US | disclosed |
| EP-2576799-A1 | PRODUCTION OF FATTY ACIDS BY HETEROLOGOUS EXPRESSION OF GENE CLUSTERS FROM MYXOBACTERIA | Universität des Saarlandes (DE) | 2013-04-10 | — | — | EP | disclosed |
| US-7666611-B2 | Lysophosphatidic acid receptor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-02-23 | — | — | US | disclosed |
| EP-1591454-B1 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR | JAPAN SCIENCE & TECH AGENCY (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20060264361-A1 | Novel lysophosphatidic acid receptor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-11-23 | — | — | US | disclosed |
| EP-1591454-A1 | NOVEL LYSOPHOSPHATIDIC ACID RECEPTOR | Japan Science and Technology Agency (JP) | 2005-11-02 | — | — | EP | disclosed |
| JP-H07258278-A | DNA POLYMERASE ALPHA INHIBITOR CONTAINING 1-O-ACYLGLYCEROL-2,3-PHOSPHATE DERIVATIVE AS ACTIVE INGREDIENT | SAGAMI CHEM RES CENTER | 1995-10-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264361-A1 | Novel lysophosphatidic acid receptor | LPAR2, LPAR4, LPAR5 | LPAR3 6/4885LPAR1 4/4885LPAR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.